180 Life Sciences Corp. (ATNF)
180 Life Sciences Statistics
Share Statistics
180 Life Sciences has 3.18M shares outstanding. The number of shares has increased by 131.83% in one year.
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | 131.83% |
| Shares Change (QoQ) | 92.52% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 2.48M |
| Failed to Deliver (FTD) Shares | 1.35K |
| FTD / Avg. Volume | 0.31% |
Short Selling Information
The latest short interest is 139.43K, so 4.39% of the outstanding shares have been sold short.
| Short Interest | 139.43K |
| Short % of Shares Out | 4.39% |
| Short % of Float | 5.17% |
| Short Ratio (days to cover) | 0.03 |
Valuation Ratios
The PE ratio is -0.08 and the forward PE ratio is -3.2. 180 Life Sciences's PEG ratio is 0.
| PE Ratio | -0.08 |
| Forward PE | -3.2 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | -12.05 |
| P/FCF Ratio | -0.14 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 180 Life Sciences Corp..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of -8.25.
| Current Ratio | 0.72 |
| Quick Ratio | 0.72 |
| Debt / Equity | -8.25 |
| Total Debt / Capitalization | 113.79 |
| Cash Flow / Debt | -10.36 |
| Interest Coverage | -300649.15 |
Financial Efficiency
Return on equity (ROE) is 156.07% and return on capital (ROIC) is -1301.55%.
| Return on Equity (ROE) | 156.07% |
| Return on Assets (ROA) | -3.79% |
| Return on Capital (ROIC) | -1301.55% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -4.98M |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.35M |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by -63.78% in the last 52 weeks. The beta is 0.14, so 180 Life Sciences's price volatility has been higher than the market average.
| Beta | 0.14 |
| 52-Week Price Change | -63.78% |
| 50-Day Moving Average | 1.57 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 31.74 |
| Average Volume (20 Days) | 437.4K |
Income Statement
| Revenue | n/a |
| Gross Profit | -105.67K |
| Operating Income | -13.48M |
| Net Income | -19.94M |
| EBITDA | -22.13M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -52.6 |
Balance Sheet
The company has 1.98M in cash and 1.05M in debt, giving a net cash position of 921.74K.
| Cash & Cash Equivalents | 1.98M |
| Total Debt | 1.05M |
| Net Cash | 921.74K |
| Retained Earnings | -127.34M |
| Total Assets | 10.47M |
| Working Capital | -5.16M |
Cash Flow
In the last 12 months, operating cash flow was -10.92M and capital expenditures 3, giving a free cash flow of -10.92M.
| Operating Cash Flow | -10.92M |
| Capital Expenditures | 3 |
| Free Cash Flow | -10.92M |
| FCF Per Share | -28.82 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4495.73% |
| FCF Yield | -295.1% |
Analyst Forecast
Currently there are no analyst rating for ATNF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 28, 2024. It was a backward split with a ratio of 1:19.
| Last Split Date | Feb 28, 2024 |
| Split Type | backward |
| Split Ratio | 1:19 |
Scores
| Altman Z-Score | -19.07 |
| Piotroski F-Score | 3 |